Triple Aim and the Hospital Readmission Reduction Program. (16th February 2021)

• Record Type: Journal Article
• Authors: Ayabakan, Sezgin; Bardhan, Indranil; Zheng, Zhiqiang (Eric)
• Is Part Of: Health services research and managerial epidemiology. Volume 8(2021)
• Publication Date: 2021-02-16
• Subjects: Hospital Readmission Reduction Program -- readmission -- length of stay -- patient satisfaction -- triple aim; Medical care -- Periodicals; Health services administration -- Periodicals; Epidemiology -- Periodicals; 362.1
• DOI: 10.1177/2333392821993704
• Languages: English
• ISSNs: 2333-3928

Abstract

Objectives: Despite substantial attention on hospital readmission rates, the impact of the Hospital Readmission Reduction Program (HRRP) on a comprehensive set of Triple Aim goals has not been studied: improve hospital quality, reduce cost, and improve patient experience. Methods: We analyze inpatient claims data from 2006 to 2015 from the Dallas Fort Worth Hospital Council Foundation with a panel of 27, 397 patients with chronic obstructive pulmonary disease and congestive heart failure. We deploy a quasi-natural experiment using a difference-in-difference specification to estimate the effect of HRRP effect on readmission rates, length of stay (LOS), and hospital satisfaction. Results: We find that the likelihood of 30-day readmissions declined by 2.6%, average LOS decreased by 7.9%, and overall hospital rating increased by 2.1% among hospitals that fell under the scope of the HRRP, compared to non-HRRP hospitals. Our results provide evidence of a spillover effect of the HRRP in terms of its impact not only on Medicare patients, but across all insurance types, and other performance measures such as cost and patient experience. Conclusion: Our findings indicate that HRRP hospitals do not trade-off reductions in readmission rates with lower quality across other patient health outcomes. Rather, we find evidence that the HRRP has affected all 3 dimensions of the Triple Aim with respect to patient and hospital outcomes.